Humana (HUM) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4448591028

Medical Insurance, Health Benefits, Pharmacy Services, Home Care

Humana Inc. is a leading health insurance company in the United States, offering a wide range of medical and specialty insurance products to individuals, employers, and government programs. Through its two main segments, Insurance and CenterWell, the company provides a diverse portfolio of health insurance plans, including Medicare, Medicaid, and commercial fully-insured medical and specialty health insurance benefits.

The company has a strong presence in the government sector, with contracts with the Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program, as well as contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Additionally, Humana offers military services, including the TRICARE T2017 East Region contract, and operates a pharmacy benefit manager business.

Humana's product offerings are comprehensive, including dental, vision, life insurance, and other supplemental health benefits. The company also provides administrative services only products to individuals and employer groups. Moreover, Humana operates pharmacies and senior-focused primary care centers, and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties.

The company sells its products through a diverse network of distribution channels, including employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. With a rich history dating back to 1961, Humana Inc. is headquartered in Louisville, Kentucky, and is committed to providing high-quality health insurance products and services to its members.

Today, Humana Inc. is a leading player in the health insurance industry, with a strong brand reputation and a commitment to improving the health and well-being of its members. With its comprehensive product portfolio, extensive distribution network, and commitment to innovation, Humana Inc. is well-positioned to continue to grow and succeed in the dynamic health insurance market.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Humana (HUM) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Humana (HUM) - Stock Price & Dividends

HUM Stock Overview

Market Cap in USD 42,121m
Sector Healthcare
Industry Healthcare Plans
GiC SubIndustry Managed Health Care
TER 0.00%
IPO / Inception 1993-01-22

HUM Stock Ratings

Growth 5y 23.7
Fundamental 37.7
Dividend 5.38
Rel. Performance vs Sector -3.49
Analysts 3.88/5
Fair Price Momentum 383.05 USD
Fair Price DCF 677.14 USD

HUM Dividends

Yield 12m 1.00%
Yield on Cost 5y 1.37%
Dividends CAGR 5y 9.98%
Payout Consistency 49.9%

HUM Growth Ratios

Growth 12m -19.62%
Growth Correlation 12m -47%
Growth Correlation 3m 50%
CAGR 5y 6.62%
CAGR/Mean DD 5y 0.64
Sharpe Ratio 12m -0.81
Alpha vs SP500 12m -45.35
Beta vs SP500 5y weekly 0.92
ValueRay RSI 65.24
Volatility GJR Garch 1y 29.70%
Price / SMA 50 5.07%
Price / SMA 200 -13.33%
Current Volume 1633.2k
Average Volume 20d 1349.8k

External Links for HUM Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of HUM stocks?
As of June 22, 2024, the stock is trading at USD 355.48 with a total of 1,633,238 shares traded.
Over the past week, the price has changed by -0.96%, over one month by -0.04%, over three months by +2.59% and over the past year by -20.82%.
What are the forecast for HUM stock price target?
According to ValueRays Forecast Model, HUM Humana will be worth about 420.6 in June 2025. The stock is currently trading at 355.48. This means that the stock has a potential upside of +18.3%.
Issuer Forecast Upside
Wallstreet Target Price 371 4.35
Analysts Target Price 587.5 65.3
ValueRay Target Price 420.6 18.3